Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Newer directions in vaccine development and utilization.

M R Hilleman

    The Journal of Infectious Diseases
    |March 1, 1985
    PubMed
    Summary

    Vaccine technology has advanced significantly, offering potential control over infectious diseases. However, challenges in funding and application hinder widespread vaccine use, especially in adults.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The enhancement and properties of the complement-fixing antigens of lymphogranuloma venereum.

    Federation proceedings·2010
    Same author

    Studies on lymphogranuloma venereum complement-fixing antigens the solubility in ether of an active fraction.

    Journal of immunology (Baltimore, Md. : 1950)·2010
    Same author

    Studies on lymphogranuloma venereum complement-fixing antigens; enhancement by phenol or boiling.

    Journal of immunology (Baltimore, Md. : 1950)·2010
    Same author

    Studies on lymphogranuloma venereum complement-fixing antigens; fractionation with organic solvents of antigens of the psittacosis lymphogranuloma venereum group.

    Journal of bacteriology·2010
    Same author

    On use of urea- and phenol-treated skin test antigens for diagnosis of lymphogranuloma venereum.

    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010
    Same author

    Double-stranded polynucleotides as interferon inducers.

    The Journal of general physiology·2009

    Area of Science:

    • Immunology and infectious disease research.
    • Biotechnology and vaccine development.

    Background:

    • Vaccine technology has evolved from early methods to modern recombinant genetics.
    • Significant progress has been made in developing vaccines for various human infectious diseases.

    Purpose of the Study:

    • To provide a prospective view of future vaccines and biotechnology.
    • To examine vaccine development for hepatitis and herpesvirus infections.
    • To discuss practical barriers to vaccine implementation.

    Main Methods:

    • Review of historical and current vaccine development technologies.
    • Analysis of case studies in hepatitis and herpesvirus vaccine research.
    • Discussion of socioeconomic and application-related challenges.

    Main Results:

    • Recombinant genetics offers new avenues for vaccine creation.
    • Hepatitis and herpesvirus infections are key examples for future vaccine strategies.
    • Vaccine use is limited by financial constraints in developing nations and application failures in developed nations, particularly among adults.

    Conclusions:

    • Continued technological advancement in vaccine development is crucial.
    • Addressing practical issues like funding and adult vaccination is essential for realizing vaccine benefits.
    • Justification for future vaccine development relies on overcoming implementation hurdles.

    Related Experiment Videos